Starling Oncology STLNW
NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT

Starling Oncology (STLNW) Change in Acquisitions & Divestments (2023 - 2024)

Starling Oncology's (STLNW) quarterly Change in Acquisitions & Divestments came in at $10.0 million in Q3 2024, up 16.62% on a YoY basis from $8.6 million in Q4 2023, and down 50.0% quarter-over-quarter from $20.0 million in Q2 2024.

Analysis

Starling Oncology (STLNW) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends

Starling Oncology (STLNW) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $10.0 million the latest figure, recorded in Q3 2024.

  • For the quarter ending Q3 2024, Change in Acquisitions & Divestments rose 16.62% year-over-year to $10.0 million; the trailing twelve-month figure through Jun 2025 stood at $10.0 million (down 83.64% YoY), and the FY2024 full-year result was $50.0 million, down 38.47% from the prior year.
  • Change in Acquisitions & Divestments slipped to $10.0 million in Q3 2024 per STLNW's latest filing, from $20.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $30.1 million in Q2 2023 and bottomed at $8.6 million in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.90 Bn 11.21 Bn 1.16 Bn
2 RadNet 5.50 Bn 4.77 Bn 88.08 Mn
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn
4 Concentra Group Holdings Parent 4.28 Bn 4.12 Bn 192.10 Mn
5 Privia Health 2.57 Bn 2.16 Bn -
6 Pediatrix Medical 2.15 Bn 1.75 Bn -
7 Progyny 2.11 Bn 1.87 Bn 89.30 Mn
8 Surgery Partners 1.85 Bn 1.63 Bn 622.10 Mn
9 U S Physical Therapy 1.18 Bn 1.15 Bn 41.94 Mn
10 Starling Oncology 4.13 Mn -36.96 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 10.00 Mn
Jun 30, 2024 20.00 Mn
Mar 31, 2024 20.00 Mn
Dec 31, 2023 12.56 Mn
Sep 30, 2023 8.58 Mn
Jun 30, 2023 30.13 Mn
Mar 31, 2023 30.00 Mn